Personal tools

MCL coexpression mm9:2196: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0004177!1.02e-20!29;UBERON:0005057!1.02e-20!29;UBERON:0002390!1.34e-19!45;UBERON:0003061!1.34e-19!45;UBERON:0002193!2.51e-19!48;UBERON:0002405!2.51e-19!48;UBERON:0000077!2.25e-18!35;UBERON:0003408!1.33e-17!24;UBERON:0002370!8.34e-17!23;UBERON:0000974!8.34e-17!23;UBERON:0004807!8.34e-17!23;UBERON:0005058!8.34e-17!23;UBERON:0003351!8.34e-17!23;UBERON:0009113!8.34e-17!23;UBERON:0003295!8.34e-17!23;UBERON:0009722!8.34e-17!23;UBERON:0005562!8.34e-17!23;UBERON:0007690!8.34e-17!23;UBERON:0006562!7.91e-16!24;UBERON:0001557!7.91e-16!24;UBERON:0001042!7.91e-16!24;UBERON:0008814!7.91e-16!24;UBERON:0009145!7.91e-16!24;UBERON:0000072!2.41e-13!27;UBERON:0001004!2.06e-11!42;UBERON:0000065!9.29e-11!41;UBERON:0003081!5.67e-10!87;UBERON:0007811!1.62e-09!36;UBERON:0000063!6.92e-09!35;UBERON:0001041!1.48e-08!80;UBERON:0000926!2.87e-08!120;UBERON:0004120!2.87e-08!120;UBERON:0006603!2.87e-08!120;UBERON:0002530!4.42e-07!65;UBERON:0000153!5.46e-07!43;UBERON:0000490!9.28e-07!66
|ontology_enrichment_uberon=UBERON:0004177!1.02e-20!29;UBERON:0005057!1.02e-20!29;UBERON:0002390!1.34e-19!45;UBERON:0003061!1.34e-19!45;UBERON:0002193!2.51e-19!48;UBERON:0002405!2.51e-19!48;UBERON:0000077!2.25e-18!35;UBERON:0003408!1.33e-17!24;UBERON:0002370!8.34e-17!23;UBERON:0000974!8.34e-17!23;UBERON:0004807!8.34e-17!23;UBERON:0005058!8.34e-17!23;UBERON:0003351!8.34e-17!23;UBERON:0009113!8.34e-17!23;UBERON:0003295!8.34e-17!23;UBERON:0009722!8.34e-17!23;UBERON:0005562!8.34e-17!23;UBERON:0007690!8.34e-17!23;UBERON:0006562!7.91e-16!24;UBERON:0001557!7.91e-16!24;UBERON:0001042!7.91e-16!24;UBERON:0008814!7.91e-16!24;UBERON:0009145!7.91e-16!24;UBERON:0000072!2.41e-13!27;UBERON:0001004!2.06e-11!42;UBERON:0000065!9.29e-11!41;UBERON:0003081!5.67e-10!87;UBERON:0007811!1.62e-09!36;UBERON:0000063!6.92e-09!35;UBERON:0001041!1.48e-08!80;UBERON:0000926!2.87e-08!120;UBERON:0004120!2.87e-08!120;UBERON:0006603!2.87e-08!120;UBERON:0002530!4.42e-07!65;UBERON:0000153!5.46e-07!43;UBERON:0000490!9.28e-07!66
|tfbs_overrepresentation_for_novel_motifs=0.641384,0.402508,0.612053,0.688265,0.483253,0.704257,0.803568,0.370124,0.381467,0.162942,0.755749,0.790506,0.37041,0.81685,0.502646,0,1.02248,0.473993,0.352304,0.683591,0.570433,1.08884,0.815872,0.481455,0.620553,0.846564,0.906602,0.727368,0.535752,0.290745,0.711848,1.12823,0.471365,0.854272,0.503207,0.623685,0.460474,0.786577,0.434783,0.40068,0.478558,0.717547,1.04032,1.26006,0.0986756,0.675898,0.938241,0.744678,1.51493,0.539131,1.0041,0.875451,0.771943,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.377213,0.205546,1.32691,0.323563,0.310084,0.318792,0.926147,1.08947,0.575233,1.75112,1.04072,0.884013,0.362446,1.20828,0.11855,0.129654,0.290918,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,1.05366,0.367176,1.14445,0.938512,0.731844,1.16494,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,0.57247,0.633483,1.25851,0.576517,0.7614,1.51002,0.476467,0.143825,0.692434,1.02384,0.456123,1.33244,0.970073,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,1.23918,0.680176,1.40022,0.839311,1.53196,0.195549,0.650785,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.293812,0.184289,1.27621,0.416214,0.838313,1.35996,0.87653,0.516549,0.63863,0.650472,1.49167,1.20739,1.09379,0.630949,0.993294,0.830321,0.459159,0.788782,0.0824127
}}
}}

Revision as of 21:02, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr17:25385077..25385095,-p@chr17:25385077..25385095
-
Mm9::chr1:184185554..184185582,+p@chr1:184185554..184185582
+
Mm9::chr5:67786945..67786950,+p@chr5:67786945..67786950
+
Mm9::chr5:67795841..67795853,+p@chr5:67795841..67795853
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
hemopoietic organ1.02e-2029
immune organ1.02e-2029
hematopoietic system1.34e-1945
blood island1.34e-1945
hemolymphoid system2.51e-1948
immune system2.51e-1948
mixed endoderm/mesoderm-derived structure2.25e-1835
gland of gut1.33e-1724
thymus8.34e-1723
neck8.34e-1723
respiratory system epithelium8.34e-1723
hemolymphoid system gland8.34e-1723
pharyngeal epithelium8.34e-1723
thymic region8.34e-1723
pharyngeal gland8.34e-1723
entire pharyngeal arch endoderm8.34e-1723
thymus primordium8.34e-1723
early pharyngeal endoderm8.34e-1723
pharynx7.91e-1624
upper respiratory tract7.91e-1624
chordate pharynx7.91e-1624
pharyngeal arch system7.91e-1624
pharyngeal region of foregut7.91e-1624
segment of respiratory tract2.41e-1327
respiratory system2.06e-1142
respiratory tract9.29e-1141
lateral plate mesoderm5.67e-1087
craniocervical region1.62e-0936
organ segment6.92e-0935
foregut1.48e-0880
mesoderm2.87e-08120
mesoderm-derived structure2.87e-08120
presumptive mesoderm2.87e-08120
gland4.42e-0765
anterior region of body5.46e-0743
unilaminar epithelium9.28e-0766


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:2196&oldid=2563416"